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Abstract  Background/Objectives:  Motivational  Enhancement  Treatment  in  Spanish  (METS)  is
a brief  intervention  aimed  at  resolving  patient  ambivalence  towards  behavior  change  that  has
demonstrated  efﬁcacy  in  substance  use  disorder  treatment  to  reduce  use  and  increase  treat-
ment engagement  in  different  populations.  In  order  to  have  evidence  for  its  implementation
in Mexico,  a  multi-site,  randomized,  two-arm,  controlled  clinical  trial  was  conducted  at  three
outpatient  addiction  treatment  centers  in  the  country  to  compare  the  effect  of  METS  with  Coun-
seling as  Usual  (CAU).  Method:  One  hundred  and  twenty  patients  were  randomized  to  receive
three sessions  of  METS  (n  =  54)  or  CAU  (n  =  66)  during  the  ﬁrst  four  weeks  of  treatment  and  were
assessed during  the  following  12  weeks.  Primary  outcome  measures  were  self-reported  days
of substance  use  and  of  treatment  services  utilization,  which  were  tested  using  Generalized
Estimating  Equations.  Results:  Results  associated  both  conditions  with  signiﬁcant  changes  in
substance use  over,  whereas  there  were  no  differences  between  conditions  in  substance  use  or
in service  utilization.  Conclusions:  Findings  do  not  support  the  hypothesis  that  METS  is  more
effective than  CAU,  but  suggest  that  brief  interventions  at  treatment  initiation  may  improve
patient outcomes.
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Intervención  de  incremento  motivacional  en  centros  ambulatorios  para  las
adicciones:  un  ensayo  aleatorizado  multi-céntrico
Resumen  Antecedentes/Objetivos:  La  Intervención  de  Incremento  Motivacional  (METS)  es
una intervención  breve  para  resolver  la  ambivalencia  del  paciente  con  respecto  a  su  com-
portamiento  y  ha  demostrado  eﬁcacia  en  distintas  poblaciones  para  reducir  el  consumo  de
sustancias e  incrementar  la  asistencia  al  tratamiento  en  adicciones.  Con  el  objetivo  de  generar
evidencia para  su  implementación  en  México,  se  desarrolló  un  ensayo  clínico  controlado,  multi-
sede, aleatorizado,  de  dos  brazos  en  tres  centros  de  tratamiento  ambulatorio  para  adicciones,
para comparar  el  efecto  de  METS  con  el  del  tratamiento  usual  (CAU).  Método:  Ciento  veinte
pacientes  fueron  aleatorizados  a  tres  sesiones  de  METS  (n  =  54)  o  CAU  (n  =  66)  durante  las
primeras cuatro  semanas  de  tratamiento  y  evaluados  durante  las  siguientes  doce.  Se  midieron
resultados  mediante  autoinforme  de  días  con  consumo  de  sustancias  y  días  de  utilización  de
servicios,  los  cuales  fueron  analizados  mediante  ecuaciones  de  estimación  generalizadas.  Resul-
tados: Los  resultados  asociaron  ambas  condiciones  a  cambios  signiﬁcativos  en  uso  de  sustancias
a lo  largo  del  tiempo,  pero  no  demostraron  diferencias  entre  condiciones  en  el  uso  de  sustancias
o en  la  utilización  de  servicios.  Conclusiones:  Los  hallazgos  contradicen  la  hipótesis  de  superi-
oridad de  METS  sobre  CAU,  pero  sugieren  que  las  intervenciones  breves  al  inicio  del  tratamiento
pudieran mejorar  la  respuesta  del  paciente.
© 2016  Asociacio´n  Espan˜ola  de  Psicolog´ıa  Conductual.  Publicado  por  Elsevier  Espan˜a,  S.L.U.
Este es  un  art´ıculo  Open  Access  bajo  la  licencia  CC  BY-NC-ND  (http://creativecommons.org/s/
h
t
a
c
t
i
(
h
a
w
i
h
d
t
d
p
a
e
t
t
R
e
a
L
V
e
c
i
a
t
p
2
1
t
w
i
h
t
(
w
C
i
s
4
2
p
a
w
d
m
a
i
e
e
p
M
T
i
2
t
I
rby-nc-nd/4.0/).
Early  patient  engagement  in  substance  abuse  treatment
as  been  widely  reported  as  a  strong  predictor  of  posi-
ive  treatment  outcomes  (Simpson  &  Joe,  2004).  In  Mexico,
chieving  such  engagement  and  retention  has  proven  to  be  a
hallenge.  Data  from  the  National  Addiction  Survey  reports
hat  only  1.0%  of  alcohol  and  9.4%  of  drug  users  seek  special-
zed  treatment  of  which  only  17.5%  and  35%  ﬁnish  treatment
Secretaría  de  Salud,  2012a,  2012b).  In  recent  years,  efforts
ave  been  made  to  make  specialized  treatment  more  avail-
ble  to  the  population  (Marín-Navarrete  et  al.,  2014)  and
hile  they  have  enhanced  the  capacity  to  reach  patients
n  need  of  treatment  (e.g.  treatment  utilization  in  alco-
ol  users  increased  13%  between  2008  and  2011);  reported
ropout  rates  suggest  there  is  still  a  need  for  interventions
hat  improve  patients’  engagement  in  treatment  (Secretaría
e  Salud,  2012a).
Motivational  Interviewing  (MI)  is  a  client-centered  thera-
eutic  approach  aimed  at  improving  treatment  engagement
nd  outcomes  (Lundahl  &  Burke,  2009).  MI  focuses  on  the
nhancement  of  the  patient’s  intrinsic  motivation  to  change
heir  substance  use  by  exploring  and  resolving  ambivalence
owards  behavior  change  (Miller  &  Rollnick,  2002;  Miller  &
ose,  2009).  Various  meta-analyses  and  reviews  support  the
ffectiveness  of  MI-based  interventions  for  treating  alcohol
nd  drug  use  (Lundahl  &  Burke,  2009;  Rubak,  Sandbeak,
auritzen,  &  Christensen,  2005;  Smedslund  et  al.,  2011;
asilaki,  Hosier,  &  Cox,  2006);  highlighting  its  low  cost  and
ase  of  implementation  in  primary  and  secondary  health-
are  settings  by  non-specialized  professionals  as  some  of
ts  strongest  attributes  (Rubak  et  al.,  2005).  Manual-based
daptations  of  MI  have  been  developed  for  clinical  trials  to
est  its  effect  as  a  brief  intervention  delivered  in  the  earlyPlease  cite  this  article  in  press  as:  Marín-Navarrete,  R.,  et
addiction  centers:  A  multisite  randomized  trial.  Internatio
http://dx.doi.org/10.1016/j.ijchp.2016.05.001
hases  of  treatment  in  different  populations  (Ball  et  al.,
007;  Carroll  et  al.,  2006;  Project  MATCH  Research  Group,
997).  A  three-session  Spanish-language  adaptation  (Motiva-
ional  Enhancement  Treatment  in  Spanish;  METS)  was  tested
i
M
U
iith  Hispanics  in  the  U.S.  and  reported  a  signiﬁcant  effect
n  alcohol-users  (Carroll  et  al.,  2009).
In  Mexico,  behavioral  interventions  for  substance  use
ave  been  tested  in  controlled  settings;  but  to  date
here  have  been  no  randomized  controlled  clinical  trials
RCT)  testing  manual-based  behavioral  interventions  in  ‘real
orld’  settings  (Rojas,  Real,  García,  &  Medina-Mora,  2011).
onsidering  the  evidence  supporting  MI-based  interventions
n  other  populations,  and  the  fact  that  a  trial  testing  METS
howed  good  results  with  Hispanics  in  the  U.S.  (in  which
9.4%  of  the  sample  were  of  Mexican  origin)  (Carroll  et  al.,
009),  we  conducted  a  study  to  test  the  effect  of  METS  com-
ared  with  Counseling  as  Usual  (CAU)  in  three  outpatient
ddiction  care  centers  in  Mexico.  We  hypothesized  that  METS
ould  be  more  effective  than  CAU  in  reducing  number  of
ays  of  substance  use  and  increasing  engagement  in  treat-
ent  (i.e.,  utilization  of  treatment  services  offered  within
nd  outside  the  treatment  centers  and  retention  to  counsel-
ng  services).  In  light  of  ﬁndings  from  the  METS  trial  (Carroll
t  al.,  2009),  we  also  hypothesized  that  METS  would  be  more
ffective  than  CAU  in  patients  reporting  alcohol  as  their
rimary  substance  of  use.
ethod
his  RCT  was  the  ﬁrst  trial  implemented  in  the  Mexican  Clin-
cal  Trials  Network  (Horigian  et  al.,  2016;  Horigian  et  al.,
015;  Marín-Navarrete  et  al.,  2014).  Considering  the  need
o  improve  mental  health  research  in  low  and  middle-
ncome  countries  (Collins  et  al.,  2011),  the  network  was  the
esult  of  a  technology  transfer  process  between  the  Mex- al.  Motivational  enhancement  treatment  in  outpatient
nal  Journal  of  Clinical  and  Health  Psychology  (2016),
can  National  Institute  of  Psychiatry  Ramón  de  la  Fuente
un˜iz  (INPRFM)  in  Mexico  and  the  University  of  Miami  in  the
nited  States  to  develop  research  infrastructure  and  capac-
ty  to  conduct  rigorous  RCTs  in  community-based  addiction
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Motivational  enhancement  treatment  in  outpatient  addictio
and  mental  health  treatment  centers  in  Mexico  (Horigian
et  al.,  2015).  This  study  was  conducted  and  monitored  in
compliance  with  Good  Clinical  Practice  (GCP)  guidelines,
which  inform  the  Mexican  regulations  for  clinical  research
with  human  subjects  (Organización  Panamericana  de  la
Salud  [OPS],  2005).  Before  trial  implementation,  all  proto-
col  procedures,  informed  consent  forms,  and  case  report
forms  were  approved  by  the  ethics  committees/institutional
review  boards  (IRB)  of  the  participating  institutions.  All
study  participants  and  counselors  provided  written  informed
consent  before  participation.  This  clinical  trial  can  be  found
at  the  International  Standard  Randomized  Clinical  Trial  Num-
ber  (ISRCTN)  registry  (Protocol  No.  ISRCTN91657311).
Study design
This  was  a  multi-site  parallel  group  superiority  trial  with
participants  randomly  assigned  to  either  METS  or  CAU  in
an  allocation  ratio  of  1:1.  This  trial  was  an  adaptation  of
a  previous  protocol  conducted  by  the  National  Institute  of
Drug  Abuse  Clinical  Trials  Network  (NIDA-CTN)  (Carroll  et  al.,
2009),  which  tested  METS  in  Hispanic  substance  users  in
the  U.S.;  therefore,  it  shares  its  basic  design  and  primary
outcome  measures.  Additional  adaptations  were  required
to  ensure  adequate  cultural  ﬁt  with  the  Mexican  popula-
tion.  For  instance,  most  case  report  forms  went  through  a
back-translation  process  and  were  reviewed  using  cognitive
laboratories  methodology  (Nolin  &  Chandler,  1996;  Ramada-
Rodilla,  Serra-Pujadas,  &  Declós-Clanchet,  2013).
Study  assessment  schedule  was  as  follows:  eligibility  and
baseline  assessments  were  performed  at  treatment  intake,
after  which,  participants  were  randomized  to  receive  3  ses-
sions  of  METS  or  3  sessions  of  CAU  over  a  28-day  period
(active  phase).  Participants  were  assessed  three  times  dur-
ing  the  active  phase  and  again  at  the  end  of  this  period
(day  28).  Follow-up  assessments  were  conducted  at  8  and
16  weeks  after  randomization.
Study sample
Participants  were  adults  (ages  between  18  and  65  years)  who
requested  outpatient  treatment  for  substance  use  at  the
study  sites,  with  any  substance  use  in  the  28  days  before  ini-
tiating  treatment,  and  were  willing  to  participate  in  all  study
procedures  (e.g.,  accept  randomization,  availability  during
16  weeks  of  participation).  Participants  that  required  imme-
diate  specialized  care  other  than  Substance  Use  Disorder
outpatient  treatment  (e.g.,  crisis  intervention  for  suicidal-
ity,  detoxiﬁcation),  faced  imminent  incarceration,  or  had  a
signiﬁcant  other  enrolled  in  the  study  were  excluded  from
participation.  Women  on  their  eight-month  of  pregnancy  or
beyond  were  also  excluded.
Counselors  inclusion  criteria  were:  being  a  member  of
the  participating  site  clinical  staff,  volunteering  to  partic-
ipate  in  the  study,  having  never  received  prior  training  in
MI,  agreeing  to  have  their  sessions  audio-taped  and  to  be
randomized  to  deliver  either  METS  or  CAU.  Fourteen  coun-Please  cite  this  article  in  press  as:  Marín-Navarrete,  R.,  et
addiction  centers:  A  multisite  randomized  trial.  Internatio
http://dx.doi.org/10.1016/j.ijchp.2016.05.001
selors  from  three  outpatient  addiction  care  centers  were
randomized  using  a  computer-based  unblocked  procedure
performed  by  the  research  team  at  the  INPRFM,  where  all
participating  counselors  were  individually  informed  of  their
M
M
o PRESS
nters  3
ssignment.  Eight  counselors  were  assigned  to  CAU  and  six
o  METS.  12  of  the  14  counselors  were  women.  Counselor
ean  age  was  37.6  years  (SD  =  11.7).  Years  of  experience
n  addiction  treatment  ranged  from  less  than  one  year  to
ore  than  20.  All  counselors  had  at  least  the  Mexican  equiv-
lent  to  a  bachelor-degree  level  of  education  in  Psychology.
hen  inquired  about  their  usual  practice  before  study  par-
icipation,  the  majority  endorsed  an  approach  based  on
ognitive-behavioral  therapy  or  an  ‘‘eclectic’’  counseling
pproach  with  no  dominant  theoretical  orientation.  There
ere  no  statistically  signiﬁcant  differences  in  counselor
ean  age,  years  of  experience,  level  of  education  and  base-
ine  counseling  approach  between  METS  and  CAU.
tudy interventions
ETS  consists  of  three  individual  manualized  counseling
essions.  During  the  sessions,  in  addition  to  strategies
ike  open-questions,  afﬁrmations,  reﬂections  and  summary
tatements,  counselor  and  patient  engage  in  structured
xercises,  with  the  aid  of  printed  handouts,  aimed  at
roviding  personal  feedback  on  substance  use,  explore
mbivalence  and  discrepancies,  and  (if  the  patient  readi-
ess  is  appropriate)  jointly  develop  a  change  plan  to  be
ollowed  in  the  course  of  treatment  (Ball  et  al.,  2007).  The
ETS  manual  and  patient  handouts  from  the  NIDA-CTN  study
Farentinos  &  Obert,  2000) were  translated  to  Spanish  and
dapted  for  Mexican  population  by  a  clinical  supervisor  from
he  INPRFM  aided  by  two  bilingual  METS  experts  who  collab-
rated  in  the  U.S.  trial.
Counseling  as  Usual  (CAU)  consisted  of  three  individual
on-manualized  counseling  sessions,  delivered  in  the  ther-
peutic  style  that  counselors  who  were  not  trained  in  METS
ould  usually  offer  at  the  participating  sites.  CAU  thera-
ists  at  all  sites  had  periodic  meetings  with  a site  director
o  discuss  progress  of  all  site  patients  and  did  not  receive
upervision  on  the  delivery  of  their  individual  counseling.
reatment process assessment
ll  sessions  from  both  study  interventions  were  audio-
ecorded  for  independent  adherence  and  competence
ating.  Two  certiﬁed  independent  raters  assessed  randomly
elected  audio-recorded  sessions  using  the  Supervisory  Rater
orm  (STR)  from  the  original  METS  study  (Santa  Ana  et  al.,
009).  The  STR  is  a  39-item  adaptation  of  the  Yale  Adher-
nce  and  Competence  Scale  (YACS)  (Carrol  et  al.,  2000)  that
easures  adherence  and  competence  in  METS-speciﬁc  con-
istent  fundamental  strategies  (e.g.,  open-ended  questions,
eﬂective  statements)  METS-speciﬁc  advanced  strategies
e.g.  pros,  cons  and  ambivalence,  change  planning),  METS
nconsistent  strategies  (e.g.  therapeutic  authority,  unso-
icited  advice,  etc.)  and  general  substance  abuse  counseling
trategies  (e.g.,  assessing  substance  use,  program  orien-
ation)  using  a  7-point  Likert  scale  (Martino,  Ball,  Nich,
rankforter,  &  Carroll,  2008; 2009;  Santa  Ana  et  al.,  2009). al.  Motivational  enhancement  treatment  in  outpatient
nal  Journal  of  Clinical  and  Health  Psychology  (2016),
ETS training and supervision
ETS  supervisors  were  proposed  by  each  site  director  based
n  their  leadership  and  years  of  professional  experience  in
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ddiction  treatment  and  were  supervised  by  METS  experts
rom  the  U.S.  All  METS  counselors  and  supervisors  partic-
pated  in  a  2-day  centralized  training  conducted  by  the
ilingual  METS  experts.  Site  supervisors  attended  a  third
raining  day  on  supervision  techniques.  Following  train-
ng,  counselors  completed  two  certiﬁcation  cases  that  were
udio-recorded  and  rated  by  each  site  supervisor  and  by
he  METS  experts  with  the  same  STR  form  used  by  inde-
endent  raters.  Adherence  and  competence  ratings  from
he  original  METS  study  were  used  for  counselor  certiﬁca-
ion  (Martino  et  al.,  2008;  Martino,  Ball,  Nich,  Frankforter,  &
arroll,  2009).  After  certiﬁcation,  site  supervisors  rated  one
andomly  selected  session  each  week  and  had  weekly  super-
ision  sessions  with  the  counselors  where  they  provided
eedback  along  with  the  METS  experts.  If  a  counselor  drifted
elow  initial  certiﬁcation  ratings,  s/he  was  suspended  from
eeing  study  participants  and  repeated  the  certiﬁcation  pro-
ess.
tudy procedures
articipants  were  recruited  from  three  outpatient  addic-
ion  care  centers,  two  in  Mexico  City  and  one  in  the  city
f  Puebla,  between  April  and  November  2012.  Each  of
he  selected  sites  represented  one  of  the  three  govern-
ent  funded  leading  treatment  institutions  in  the  country:
ational  Institute  of  Psychiatry  Ramon  de  la  Fuente  Mun˜iz,
ational  Center  for  Prevention  and  Control  of  Addictions,
nd  Youth  Integration  Centers.  Recruitment  target  was  of
20  randomized  participants,  with  a  goal  of  40  participants
er  site.  A  trained  research  assistant  (RA)  recruited  par-
icipants  at  each  site,  screened  them  for  eligibility,  and
onducted  randomization  and  study  assessment  procedures
n-site.  Randomization  was  performed  with  a  computer-
ased  ‘‘urn  randomization’’  procedure  (Wei  &  Lachin,  1988)
alanced  by  gender  and  primary  substance  of  use,  which
as  programmed  into  an  online  clinical  trial  management
oftware.  After  randomization,  the  RA  arranged  a  ﬁrst  visit
ith  a  site  counselor  corresponding  to  the  assigned  treat-
ent  condition.  Site  RAs  contacted  all  participants  by  phone
r  e-mail  before  a  scheduled  visit  to  conﬁrm  visit  appoint-
ents.  Participants  received  gift  cards  for  completing  study
ssessments.
The  safety-monitoring  plan  involved  a  continuous
ssessment  of  Adverse  Events  (AE),  queried  through  a  semi-
tructured  interview  at  each  study  visit  by  the  site  RA.
ood  Clinical  Practice  (GCP)  deﬁnitions  and  classiﬁcations
f  AEs  for  seriousness,  severity,  relatedness  and  resolu-
ion  status  were  used  (Organización  Panamericana  de  Salud,
005).  Only  events  that  were  serious  or  study-related  were
eported  to  the  IRBs  within  10  days  of  occurrence.  All  other
dverse  events  were  reported  quarterly.
utcome measures
rimary  outcomes  for  this  study  were:  days  of  substance
se  and  days  of  treatment  services  utilization.  The  followingPlease  cite  this  article  in  press  as:  Marín-Navarrete,  R.,  et
addiction  centers:  A  multisite  randomized  trial.  Internatio
http://dx.doi.org/10.1016/j.ijchp.2016.05.001
easures  were  used.
Substance  Use  Calendar  (SUC).  Based  on  the  Time-
ine  Follow-Back  interview  (Fals-Stewart,  O’Farrell,  Freitas,
cFarlin,  &  Rutigliano,  2000;  Sobell  &  Sobell,  1992),  this
e
n
o
c PRESS
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easure  uses  a  calendar  method  to  record  daily  substance
se  (alcohol,  cocaine,  marijuana,  opioids,  tranquilizers,
mphetamine-like  stimulants,  heroin,  hallucinogens,  and
obacco).  The  SUC  was  used  to  assess  substance  use  at  base-
ine,  over  the  course  of  treatment  and  follow-up.  Urine
oxicology  screens  were  used  to  conﬁrm  reported  substance
se  at  each  study  visit  (Donovan  et  al.,  2012).
Treatment  Utilization  Form  (TUF).  An  interview-based
ssessment  was  used  to  register  self-reported  utilization
f  treatment  services  from  the  active  phase  of  treatment
hrough  the  last  follow-up  assessment.  Utilization  of  treat-
ent  services  was  assessed  in  days  of  attendance  to  study
reatment  sessions  and  to  other  treatment  services  offered
ithin  and  outside  the  sites.  Treatment  services  considered
or  this  measure  were:  counseling  services  (group  or  indi-
idual  counseling  sessions),  mutual-aid  groups  (Alcoholics
nonymous,  12-step  based  programs),  childcare,  medical,
sychiatric,  social  work,  legal,  and  family  services.
tatistical analysis
ecause  participants,  RAs  and  counselors  were  aware  of
he  allocated  group,  investigators  and  data  analysts  were
linded  during  data  analysis.  Statistical  power  analysis
as  calculated  using  PASS  12  (Hintze,  2013).  120  par-
icipants  were  sufﬁcient  to  have  80%  power  to  show  a
ate  ratio  of  1.50  between  the  two  conditions.  Count
istributed  outcomes  were  tested  using  Generalized  Esti-
ating  Equations  (GEE).  Data  was  preliminarily  examined
o  assess  for  over  dispersion.  Examination  of  ﬁt  statistics
nd  estimated  scale  parameters  showed  that  a  negative
inomial  speciﬁcation  ﬁtted  better  than  a Poisson  and
n  autoregressive  correlation  structure  ﬁtted  better  than
ther  alternatives.  Treatment  effect  was  assessed  using
n  ‘‘intention-to-treat’’  approach.  This  analysis  procedure
llows  the  inclusion  of  all  participants  regardless  of  the  pres-
nce  of  any  missing  data  at  particular  assessments.  Time
as  handled  as  a  classiﬁcation  variable,  thus  the  primary
est  of  the  hypothesis  (the  time  by  treatment  interaction)
ssessed  whether  the  pattern  of  means  over  time  differed
cross  the  two  treatment  groups.  Prior  to  testing  the  primary
ypothesis  of  the  impact  of  treatment  on  days  of  sub-
tance  use,  we  examined  the  appropriateness  of  combining
esults  across  sites  (Feaster,  Mikulich-Gilbertson,  &  Brinka,
012)  and  by  whether  alcohol  was  the  primary  substance
f  abuse  because  the  original  METS  trial  had  found  differ-
nt  results  for  alcohol  users.  To  accomplish  this,  models
ere  run  with  classiﬁcation  variables  for  time,  treatment
ssignment  and  either  site  or  alcohol  as  primary  substance
f  abuse,  each  with  two-way  and  three-way  interactions.
f  the  higher  order  interactions  were  signiﬁcant,  results  of
reatment  by  subgroup  are  reported;  otherwise  the  primary
est  did  not  include  these  interactions.  To  assess  counselors’
dherence  and  competence,  we  conducted  mixed  models
ith  Site,  Treatment  Assignment  and  Treatment  Assignment
y  Site  included  as  ﬁxed  effects.  Models  were  estimated
sing  Proc  Mixed  in  SAS  9.2.  These  models  included  random al.  Motivational  enhancement  treatment  in  outpatient
nal  Journal  of  Clinical  and  Health  Psychology  (2016),
ffects  for  both  patient  and  counselors  to  account  for  the
esting  of  repeated  ratings  within  a  participant  and  nesting
f  participants  within  counselors.  Degrees  of  freedom  were
alculated  using  Satterthwaite’s  method  (Satterthwaite,
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1946).  For  all  outcomes,  Cohen’s  d  was  calculated  to  provide
an  estimate  of  effect  size  for  each  condition  across  and
within  each  site  for  the  outcome  variables.
Results
Study  performance  and  retention
A  total  of  136  participants  were  enrolled  in  the  study.  Of
these,  only  16  did  not  meet  the  inclusion/exclusion  criteria
resulting  in  120  randomized  participants  of  whom  91%  com-
pleted  all  study  treatment  sessions,  and  93%  were  retained
throughout  all  study  phases  (see  Figure  1).Please  cite  this  article  in  press  as:  Marín-Navarrete,  R.,  et
addiction  centers:  A  multisite  randomized  trial.  Internatio
http://dx.doi.org/10.1016/j.ijchp.2016.05.001
Participant  safety
Three  SAEs  were  identiﬁed  during  the  study  and  none  was
related  to  study  procedures  or  interventions.  Only  one
u
o
b
i
Assessed for eligibili
(n= 136)
Ex
-D
•
•
•
•
•
•
•
•
•
-D
Randomized (n=120
Patients allocated to CAU (n=66)
-Completed intervention (n=60)
-Did not complete intervention (n=6)
-Received only 1 sessions (n=0)
-Received only 2 sessions (n=6)
Counselors allocated to CAU (n=8)
-Patients treated at each center
• (Median=22, min=20, max=24)
-Patients treated by each counselor
• (Median=8; min=0; max=13)
Completed post-treatment assessment
(28 days) (n=64)
Completed follow-Up 1 assessment
(Week 8)(n=62)
Completed follow-up 2 assessment
(Week 16) (n =65)
Analyzed (n =66)
Figure  1  CONSORT  Diagram.  Participant  recruitment  and  randomi
Note. CAU  =  Conuselling  as  Usual;  METS  =  Motivational  Enhancement   PRESS
nters  5
on-serious  event  was  related  to  study  procedures  (an
ttempted  assault  linked  to  delivery  of  study  assessment
ompensation).  All  events  were  resolved  before  study  ter-
ination.
articipant  characteristics
egarding  participant  demographics,  mean  age  was  30.1
SD  =  9.2)  years;  most  of  the  participants  were  male  (82.5%)
see  Table  1).  The  most  frequently  reported  main  substance
f  abuse  was  alcohol  (37.5%),  followed  by  cannabis  (28.3%)
nd  cocaine  (24.2%).  In  terms  of  baseline  levels  of  substance al.  Motivational  enhancement  treatment  in  outpatient
nal  Journal  of  Clinical  and  Health  Psychology  (2016),
se,  51.7%  of  the  population  reported  between  1-10  days
f  substance  use,  21.7%  between  11-20  days,  and  26.7%
etween  21-28  days.  Baseline  characteristics  of  the  sample,
ncluding  the  description  of  the  association  with  comorbid
ty
cluded ( n =  16)
id not meet inclusion/exclusion c rite ria ( n = 15)
Cognitive impai rment ( n=3)
 Homicidal/suicidal ( n= 3 )
Unable  to give  and sign  informed  consent ( n=1 )
Unstab le living a rrangement ( n=1)
Unavai lable  or unwilling  to be c ontacted in  the nex t 
4 months (n= 2 )
Not seeking outpatient tr eatmen t (n=1 )
Unwil ling to b e randomized ( n= 1 )
Facing  incarcerat ion or lega l sent ence ( n=2 )
 Significan t othe r also enrolle d (n= 1)
id not complete baseline ass essments ( n = 1)
)
Patients Allocated to METS (n=54)
-Completed intervention ( n=49)
-Did not complete intervention  (n = 5)
-Received only  1 sessions ( n = 0)
-Received only  2 sessions ( n=5)
Counselors allocated to METS (n=6)
-Patients treated at each cente r
• (Median=18, min=14, max=  24)
-Patients treated by each counselor  
• (Median=9; min=5; max=5)
Completed p ost-treatment as sessment
(28 days) (n=51)
Completed fol low-up 1 assessment
(Week 8) (n=49)
Completed fol low-up 2 assessment
(Week 16) (n=49)
Analyzed  (n=54)
zation.
Treatment  (Spanish).
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Table  1  Participant  demographics  by  site.
Site  1
(n =  44)
Site  2
(n =  38)
Site  3
(n  =  38)
Total
(n  =  120)
Signiﬁcance
between  groups
Variable  Mean
or  %
SD  Mean
or  %
SD  Mean
or  %
SD  Mean
or  %
SD  F  or  2 df  p
Age  31.4  9.8  28.5  9.05  30.1  8.6  30.1  9.2  1.02  2  .36
Years or  Education 10.8  3.6  11.5  2.44  9.6  2.5  10.6  3.0  4.04  2  .02
Gender
Male 86.4  89.5  71.1  82.5
5.18 2 .08Female 13.6  10.5  28.9  17.5
Marital Status
Married/Cohabiting  27.3  21.1  23.7  24.2
4.67 8 .79Separated/Divorced  18.2  21.1  18.4  19.2
Never Married  54.5  57.9  57.9  56.7
Employment  (Past  3  years)a
Paid  Activity 81.8  63.9  73.0  73.5
3.27 2 .19Unpaid Activity  18.2  36.1  27.0  26.5
Employment  (Past  30  days)a
Paid  Activity  47.7  61.1  54.1  53.8
1.42 2 .49Unpaid Activity  52.3  38.9  45.9  46.2
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services  available  would  differ),  it  was  deemed  adequate  to
perform  an  analysis  regarding  counseling  services  utilization
separately.  There  was  no  difference  in  the  relative  changes
in  counseling  service  utilization  over  time  in  the  two  treat-
ment  conditions  by  either  site  [2 (6)  =  1.74,  p  = .942]  or  by
alcohol  as  main  substance  of  abuse  [2 (3)  =  3.97,  p  =  .266].
There  was  no  signiﬁcant  difference  across  conditions  in  the
pattern  of  means  over  time  in  counseling  services  utilization
[2 (3)  =  .82,  p =  .844].  There  was  a  signiﬁcant  difference
in  the  patterns  of  means  over  time  in  level  of  counseling
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Baseline (0),  Active phas e (1),  and  Foll ow-up  (2,3, 4)
METS CAU
Figure  2  Mean  days  of  any  substance  use  by  time  Treat-
ment condition  by  Time  (as  phase)  interaction  for  28  daysNote.
a 3 missing values
onditions  have  been  published  by  Marín-Navarrete  et  al.
2014).
ypotheses  testing
ubstance  Use.  There  was  no  difference  in  the  relative
hanges  in  the  days  of  substance  use  over  time  in  the
wo  treatment  conditions  by  either  site  [2 (8)  =  11.27,
 =  .188]  or  by  alcohol  as  main  substance  of  abuse  [2
4)  =  2.74,  p  =  .602].  We  therefore  present  the  test  of  the
rimary  hypothesis  aggregated  across  site  and  across  major
ubstance  used.  There  was  a  signiﬁcant  difference  in  the
atterns  of  means  over  time  in  level  of  substance  use
2 (4)  =  11.58,  p  =  .021]  (see  Figure  2).  Examination  of  the
oefﬁcients  associated  with  the  difference  in  treatments  at
ach  individual  time  showed  that  at  no-time  were  the  mean
ays  of  drug  use  different  between  the  two  conditions  (see
able  2).
Service  utilization.  There  was  no  difference  in  the  rel-
tive  changes  in  service  utilization  over  time  in  the  two
reatment  conditions  by  either  site  [2 (6)  =  6.59,  p  =  .361]
r  by  alcohol  as  main  substance  of  abuse  [2 (6)  =  3.67,
 =  .300].  There  was,  however,  a  difference  in  the  pattern  of
ervice  utilization  over  time  across  sites,  which  did  not  dif-
er  by  treatment  assignment  [2 (6)  =  12.62,  p  =  .049].  The
mpact  of  treatment  condition  on  service  utilization  over
ime  was  therefore  tested  across  site  and  main  substance
f  abuse,  but  allowing  for  differences  in  levels  over  time  by
ite.  There  was  not  a  signiﬁcant  difference  in  service  uti-Please  cite  this  article  in  press  as:  Marín-Navarrete,  R.,  et  al.  Motivational  enhancement  treatment  in  outpatient
addiction  centers:  A  multisite  randomized  trial.  International  Journal  of  Clinical  and  Health  Psychology  (2016),
http://dx.doi.org/10.1016/j.ijchp.2016.05.001
ization  over  time  across  treatment  conditions  [2 (3)  =  .65,
 =  .885]  (see  Table  2).
Because  of  differences  in  counseling  services  offered
etween  sites  (e.g.,  number  of  additional  counseling
of any  substance  use  at  28  days  (Active  Phase)  (1),  8-weeks
(2), 12  weeks  (3)  and  16  weeks  (4)  after  randomization.Note.
CAU  =  Counseling  as  Usual,  METS  =  Motivational  Enhancement
Treatment  (Spanish).
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Table  2  Substance  Use  and  Service  Utilization  effect  size  (Cohen’s  d)  by  treatment  condition  and  site.
Outcome  measure  Site  1
(n  =  44)
Site  2
(n  =  38)
Site  3
(n  =  38)
Total
(n  =  120)
CAU  METS  CAU  METS  CAU  METS  CAU  METS
Days  of  primary  substance  use  (active  phasea)
Mean 9.1  13.92  6.33  10.14  9.77  7.5  8.32  11.04
SD 7.97  9.63  6.66  8.50  8.08  10.49  7.60  9.84
Effect size  (95%  CI)  −0.55  (−1.16,  0.08)  −0.50  (−1.21,  0.18)  0.24  (−0.92,  0.42)  −0.31  (−0.68,  0.05)
Days of  primary  substance  use  (follow-upb)
Mean  30.5  25.96  17.21  23.71  21.59  19.63  22.70  23.5
SD 26.74  22.20  16.12  19.77  20.44  22.28  21.59  21.39
Effect size  (95%  CI)  0.19  (−0.43,  0.8)  −0.36  (−1.06,  0.31)  0.09  (−0.76,  0.57)  −0.04  (−0.37,  0.36)
Days of  service  utilization  (from  active  phasea through  follow-upb)
Mean 31.55  12.21  10.04  10.5  8.27  16.56  15.97  13.06
SD 63.13  10.97  7.46  17.48  4.70  20.28  36.05  15.79
Effect size  (95%  CI)  −0.43  (−1.07,  0.17)  0.03  (−0.72,  0.64)  0.56  (−0.07,  1.29)  −0.11  (−0.26,  0.46)
Days of  counseling  services  utilization  (from  active  phasea through  follow-upb)
Mean 3.3  3.13  3.08  1.93  2.23  3  2.86  2.78
SD 6.67  6.32  4.06  2.40  1.90  3.35  4.50  4.71
Effect size  (95%  CI) −0.03  (−0.64,  0.58) −0.35  (−1.01,  0.36)  0.28  (−0.37,  0.97)  −0.02  (−0.34,  0.38)
Note.
a Active phase = Weeks 1-3.
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services  utilization  by  site  that  was  not  related  to  treatment
condition  [2 (6)  =  17.24,  p  =  .008].
METS  versus  CAU  ﬁdelity
Analysis  of  independent  ratings  with  STR  showed  that  METS
counselors  demonstrated  signiﬁcantly  higher  means  than
CAU  counselors  in  METS  consistent  fundamental  strategies  in
adherence  [F  (1,  14.1)  =  127.55,  p  <  .0001]  and  competence
[F  (1,  12.9)  =  94.78,  p  <  .0001].  In  METS  consistent  advanced
strategies,  METS  counselors  also  had  signiﬁcantly  higher
scores  than  CAU  counselors  in  adherence  [F  (1,  13)  =  168.49,
p  <  .0001]  and  competence  [F  (1,346)  =  33.82,  p  <  .0001].
CAU  counselors  had  signiﬁcantly  higher  scores  in  METS  incon-
sistent  strategies  than  METS  counselors  in  adherence  [F  (1,
10.2)  =  163.9,  p  <  .0001]  and  competence  [F  (1,214)  =  35.18,
p  <  .0001].  In  addition,  a  signiﬁcant  treatment  by  site  inter-
action  was  found  in  METS  inconsistent  strategies  [F  (2,
10.2)  =  10.77,  p  =  .003]  where  differences  among  conditions
were  larger  in  Site  1  (see  Table  3).
Discussion
This  study  compared  the  effect  of  METS  and  CAU  in  three
outpatient  addiction  care  centers  in  Mexico.  Results  did  not
support  the  hypothesis  that  METS  is  more  effective  than
CAU  in  increasing  treatment  engagement  and  reducing  days
of  substance  use.  While  there  was  a  signiﬁcant  time  effectPlease  cite  this  article  in  press  as:  Marín-Navarrete,  R.,  et
addiction  centers:  A  multisite  randomized  trial.  Internatio
http://dx.doi.org/10.1016/j.ijchp.2016.05.001
for  reduction  in  days  of  substance  use,  there  were  no  time
points  in  which  the  two  conditions  had  signiﬁcantly  differ-
ent  days  of  substance  use.  Therefore,  our  ﬁndings  suggest
that  both  METS  and  CAU  had  an  effect  in  reducing  days  of
i
(
iubstance  use  in  the  whole  study  sample,  without  retur-
ing  to  baseline  levels,  even  after  ﬁnishing  the  active  phase
f  treatment.  This  lack  of  signiﬁcant  differences  in  study
utcomes  between  conditions  should  be  interpreted  in  the
ontext  of  the  high  study  retention  and  study  treatment
xposure  observed  in  the  sample.  The  majority  of  partici-
ants  in  both  METS  (90.7%)  and  CAU  (90.9%)  were  exposed
o  their  three  study  treatment  sessions,  and  were  constantly
ontacted  by  the  site  RA  to  attend  their  study  assessments
t  the  treatment  center  throughout  the  4  months  of  study
uration.  Results  from  the  original  METS  study  also  showed
o  signiﬁcant  differences  between  conditions  with  a  pattern
f  decrease  from  baseline  substance  use  in  both  conditions,
nd  also  achieved  high  retention  rates  in  a  population  hard
o  retain  in  treatment  (Carroll  et  al.,  2009).  Overall,  ﬁndings
rom  both  trials  may  show  that,  regardless  of  the  therapeutic
pproach,  individual  counseling  delivered  at  the  beginning
f  treatment  along  with  the  implementation  of  constant
ontact  efforts,  might  boost  the  effect  of  treatment  in  the
atino  and  Mexican  populations
Another  possible  interpretation  of  these  ﬁndings  is  that
quivalent  results  between  interventions  in  the  whole  sam-
le  could  be  attributed  to  trial  participation.  It  has  been
ocumented  that  clinical  trial  participation  has  an  impact  on
atient  outcomes  as  an  effect  of  the  heightened  attention
oward  participating-patients,  commonly  referred  as  ‘‘trial
ffect’’  or  ‘‘research  participation  effect’’  (McCambridge,
itton,  &  Elbourne,  2014).  Unfortunately,  evidence  is
eeded  in  order  to  assess  the  size  of  such  effects  in  behav- al.  Motivational  enhancement  treatment  in  outpatient
nal  Journal  of  Clinical  and  Health  Psychology  (2016),
oral  trials  and  how  to  control  for  this  possible  source  of  bias
McCambridge  at  al.,  2014).
For  the  second  hypothesis  regarding  improved  outcomes
n  alcohol  users,  when  comparing  the  effect  of  METS  against
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Table  3  METS  and  CAU  adherence  and  competence  scores  for  three  groups  of  counselor  skills  by  treatment  condition  and  site.
Scale Total
(n  =  13)
Site  1
(n  =  4)
Site  2
(n  =  4)
Site  3
(n  =  5)
Treatment  condition  Site  Treatment  condition
x  Site  interaction
METS  CAU  METS  CAU  METS  CAU  METS  CAU  F  df  p  F  df  p  F  df  p
METS-Consistent  Basic  skills
Adherence
M  4.84  3.77  4.90  3.87  4.52  3.74  5.03  3.70 127.55 1,14.1 <  .0001  2.77  2,13.9  .097  2.79  2,13.9  .095
SD 0.57  0.74  0.55  0.88  0.55  0.62  0.52  0.73
n 157  191  71  59  39  67  47  65
Competence
M 4.20  3.70  4.26  3.64  4.15  3.88  4.17  3.57 94.78  1,12.9  <  .0001  2.81  2,12.8  .098  4.70  2,12.8  .030
SD 0.41  0.32  0.41  0.31  0.43  0.28  0.40  0.29
n 157  191  71  59  39  67  47  65
METS-Consistent  Advanced  skills
Adherence
M  3.17  2.00  3.36  2.04  2.77  1.86  3.21  2.11 168.49 1,13 <  .0001 7.32 2,12.9 .008 1.84 2,12.9 .198
SD 0.67  0.57  0.62  0.59  0.69  0.51  0.60  0.59
n 157  191  71  59  39  67  47  65
Competence
M 4.05  3.85  4.04  3.78  4.00  3.92  4.09  3.85 33.82  3,346  <  .0001  1.36  2,346  .257  2.73  2,346  .067
SD 0.30  0.31  0.26  0.32  0.36  0.26  0.30  0.34
n 157  189  71  59  39  65  47  65
METS--Inconsistent  skills
Adherence
M  1.04  1.81  1.03  2.21  1.03  1.57  1.07  1.69 163.9  1,10.2 <
.0001
9.3  2,10.2  .005  10.77  2,10.2  .003
SD 0.10  0.50  0.07  0.48  0.12  0.36  0.12  0.41
n 157  191  71  59  39  67  47  65
Competence
M 3.63  4.10  3.58  4.07  3.38  4.09  3.75  4.12 35.18  1,214 <
.0001
1.77 2,214  .173  1.07  2,214  .344
SD 0.45  0.40  0.45  0.32  0.48  0.44  0.43  0.42
n 31  183  13  59  4  62  14  62
Standard  Counseling
Adherence
M  1.59  2.12  1.71  2.37  1.53  1.92  1.47  2.10 91.28  1,13.4 <
.0001
10.36  2,13.3  .002  2.30  2,13.3  .139
SD 0.29  0.50  0.30  0.46  0.29  0.42  0.22  0.50
n 157  191  71  59  39  67  47  65
Competence
M 3.99  3.94  4.03  3.98  3.93  3.98  3.97  3.87 1.24 1,14.4 .283  2.71  2,14  .10  1.81  2,14  .20
SD 0.33  0.25  0.32  0.21  0.35  0.29  0.34  0.22
n 154  190  71  59  37  67  46  64
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CAU  in  primary  alcohol  users,  results  did  not  show  any  added
beneﬁt  from  METS,  either  in  alcohol  use  or  service  utiliza-
tion  outcomes  compared  with  the  whole  sample;  differing
with  ﬁndings  from  the  U.S.  METS  study  (Carroll  et  al.,  2009).
While  the  sample  in  the  U.S.  trial  was  larger  and  compar-
isons  should  be  taken  with  caution,  this  ﬁnding  stresses  the
possible  difference  in  effect  of  tested  EBPs  when  transferred
to  other  populations  (Patel  &  Saxena,  2014).
The  fact  that  this  study  was  implemented  in  three  dif-
ferent  outpatient  clinical  settings  that  provide  services  to
a  heterogeneous  population  of  treatment  seekers  (Marín-
Navarrete  et  al.,  2014)  may  have  also  contributed  to  the
lack  of  signiﬁcant  differences  between  conditions.  Results
showed  that  there  were  differences  between  sites  (inde-
pendent  of  treatment  condition)  in  service  utilization,  which
may  suggest  that  many  variables  in  the  patients  (e.g.  sever-
ity  of  substance  use,  presence  or  absence  of  co-occurring
disorders,  individual  and  system  level  barriers  to  treatment,
etc.),  as  well  as  the  variability  of  services  offered  within
sites  (e.g.  group  drug  counseling,  psychiatric  treatment,
etc.)  might  be  moderators  of  the  effect  observed  at  the
sites  (Carroll  et  al.,  2009).  More  complex  sub-group  analyses
could  help  identify  which  kind  of  patients  in  which  settings
received  more  therapeutic  beneﬁt  from  METS  and  could
inform  its  dissemination  (Carroll,  2012).  However,  such  anal-
ysis  would  be  difﬁcult  considering  sample  size  limitations.
This  study  has  various  limitations.  First,  despite  its  sta-
tistical  power,  sample  size  and  number  of  sites  were  limited
in  this  study.  As  mentioned  above,  a  larger  sample  may  have
permitted  more  complex  analysis  of  subgroup  observations
and  other  variable  interactions.  Second,  service  utilization
measurement  in  this  study  may  have  been  impacted  by  the
fact  that  in  Mexico,  mental  health  care  services  are  under-
utilized  regardless  of  level  of  addiction  severity  or  perceived
need  for  treatment  (Berenzon  Gorn,  Medina-Mora,  &  Lara-
Cantú,  2003;  Borges  et  al.,  2006),  so  an  alternative  approach
that  considers  measuring  engagement  in  other  help-seeking
behaviors  idiosyncratic  to  the  Mexican  population  (e.g.  seek-
ing  support  in  the  family  or  within  the  community)  at
follow-up  should  be  considered  for  future  trials.  Third,
we  did  not  perform  any  viability,  acceptability  or  cultural
adequateness  analyses  of  METS  with  Mexican  patients  and
counselors  before  trial  implementation.
Finally,  another  possible  limitation  of  the  study  is  the
capacity  of  the  STR  to  fully  characterize  what  happened
during  intervention  sessions,  since  it  is  focused  on  rating
counselor  adherence  to  METS  consistent  and  inconsistent
strategies,  but  does  not  assess  patient  speech  and  behaviors.
A  systematic  review  by  Magill  et  al.  (2014)  on  MI  process  sup-
ports  that  better  outcomes  rely  on  a  dynamic  relationship
between  MI  consistent  strategies  and  increased  ﬂuctuations
in  the  patient’s  language  between  willingness  to  change
behavior  or  to  maintain  the  status  quo;  unfortunately,  the
STR  form  does  not  allow  testing  this  technical  hypothe-
sis.  Additionally,  a  more  detailed  process  analysis  may  help
establish  counselor-patient  interactions  that  may  be  linked
to  better  outcomes  in  the  Mexican  population,  and  therefore
help  identify  common  factors  between  the  two  interventionsPlease  cite  this  article  in  press  as:  Marín-Navarrete,  R.,  et
addiction  centers:  A  multisite  randomized  trial.  Internatio
http://dx.doi.org/10.1016/j.ijchp.2016.05.001
that  could  explain  why  both  were  equally  effective  (Laska,
Gurman  &  Wampold,  2014).
In  spite  of  these  limitations,  this  study  has  impor-
tant  strengths.  This  study  is  the  ﬁrst  in  Mexico  to  test
B PRESS
nters  9
he  effect  of  a  behavioral  intervention  for  substance  use
reatment  following  clinical  trial  standards.  Therefore,
ts  strengths  include  recruitment  and  randomization  of  a
iverse  sample  of  treatment-seekers,  delivery  of  inter-
entions  by  randomized  counselors  currently  working  in
eal-world  treatment  settings,  choice  of  an  active  control
ntervention,  independent  ratings  to  ensure  discriminability
etween  interventions  and  intensive  training,  certiﬁcation
nd  supervision  efforts  on  the  study  intervention.
Overall,  despite  the  lack  of  conclusive  ﬁndings  on  the
ffect  of  METS  against  CAU,  this  study  adds  a  trial  to  the
xisting  evidence  that  supports  the  need  to  study  how  brief
nterventions  for  substance  use  work  (Hingson  &  Compton,
014) by  analyzing  treatment  effects  moderators  and  medi-
tors  (Beutler,  Someah,  Kimpara,  &  Miller,  2016) and  raises
mportant  questions  for  further  treatment  research  with
his  population.  Finally,  this  project  constituted  an  unprece-
ented  collaboration  in  Mexico  between  researchers  and
ommunity  service  providers,  proving  that  rigorous  trials  are
easible  in  Mexico,  thus  opening  the  door  to  future  studies
f  this  nature  in  the  country.
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